NexLife (94/100): MD/DO oversight, dual 503A/503B, Care360 coaching, $186/mo flat. Henry Meds (78/100): NP/PA async-only, 503A, $297/mo.
NexLife (94/100): MD/DO oversight, dual 503A/503B, Care360 coaching, $186/mo flat. Henry Meds (78/100): NP/PA async-only, 503A, $297/mo.
For the full clinical evidence, see clinical research and main comparison page.
Compounded semaglutide + tirzepatide · MD/DO oversight
*12-month plan · flat rate · all titration doses
Or call (949) 818-8000